{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:06:15Z","timestamp":1789329975115,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00555658"],"award-info":[{"award-number":["RS-2025-00555658"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00508681"],"award-info":[{"award-number":["RS-2024-00508681"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070873"],"award-info":[{"award-number":["RS-2022-NR070873"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3A9G8017220"],"award-info":[{"award-number":["2022M3A9G8017220"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00439794"],"award-info":[{"award-number":["RS-2024-00439794"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.037","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:43:24Z","timestamp":1787701404000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of synthetic TBK1 activator inducing type I interferon-mediated antiviral and antitumor immunity"],"prefix":"10.1016","author":[{"given":"Kwiwan","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbeom","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taegwan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-mi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Eun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-4722","authenticated-orcid":false,"given":"Eun-Hye","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byungil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Yeon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3248-4614","authenticated-orcid":false,"given":"Jung Sang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Geun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-4513","authenticated-orcid":false,"given":"Wonsik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.037_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tim.2017.01.001","article-title":"Transcriptional Regulation of Antiviral Interferon-Stimulated Genes","volume":"25","author":"Wang","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.08.037_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.037_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","article-title":"Host-directed immunotherapy of viral and bacterial infections: past, present and future","volume":"23","author":"Wallis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tibs.2022.09.005","article-title":"Recent and future perspectives on engineering interferons and other cytokines as therapeutics","volume":"48","author":"Aung","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ymthe.2026.08.037_bib7","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1038\/s41467-021-26112-2","article-title":"Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.037_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.037_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.08.037_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01913-17","article-title":"Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway","volume":"92","author":"Gall","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib11","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1038\/s41467-024-50234-y","article-title":"An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models","volume":"15","author":"Leekha","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.037_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005324","article-title":"Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses","volume":"11","author":"Sali","year":"2015","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.08.037_bib13","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/jmv.24809","article-title":"SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants","volume":"89","author":"Jones","year":"2017","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211818","article-title":"A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice","volume":"219","author":"Mao","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.08.037_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41467-021-22033-2","article-title":"Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway","volume":"12","author":"Alicea-Torres","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.037_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41590-022-01152-y","article-title":"Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells","volume":"23","author":"Sumida","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2017.01.004","article-title":"Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment","volume":"31","author":"Katlinski","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.08.037_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5'-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.037_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.037_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ni.1779","article-title":"RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate","volume":"10","author":"Ablasser","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00003495-199550050-00007","article-title":"Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis","volume":"50","author":"Haria","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2026.08.037_bib24","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.4049\/jimmunol.1290060","article-title":"IFN-alpha in the treatment of melanoma","volume":"189","author":"Tarhini","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib25","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fimmu.2018.01135","article-title":"A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses","volume":"9","author":"Michalska","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib26","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/MCB.00344-15","article-title":"Fine-Tuning of the RIG-I-Like Receptor\/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3\/beta-Catenin Pathway","volume":"35","author":"Khan","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41586-019-1228-x","article-title":"A conserved PLPLRT\/SD motif of STING mediates the recruitment and activation of TBK1","volume":"569","author":"Zhao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.037_bib28","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acsmedchemlett.9b00027","article-title":"Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor","volume":"10","author":"Thomson","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ymthe.2026.08.037_bib29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.037_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.037_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","article-title":"The multiple roles of interferon regulatory factor family in health and disease","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.08.037_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev-immunol-101320-031931","article-title":"Spatiotemporal Adaptations of Macrophage and Dendritic Cell Development and Function","volume":"40","author":"Roquilly","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0008-8749(03)00128-X","article-title":"Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC","volume":"222","author":"Met","year":"2003","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13046-022-02352-y","article-title":"The role of TBK1 in cancer pathogenesis and anticancer immunity","volume":"41","author":"Runde","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.037_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.08.037_bib38","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymthe.2026.08.037_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ymthe.2026.08.037_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105473","article-title":"Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay","volume":"209","author":"Jeong","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2026.08.037_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/cpmc.105","article-title":"Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2","volume":"57","author":"Mendoza","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib42","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.037_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.037_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.037_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.037_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105254","article-title":"Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses","volume":"25","author":"Jeong","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2026.08.037_bib47","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.7150\/thno.74903","article-title":"Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killing","volume":"12","author":"Liang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.08.037_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:01:25Z","timestamp":1789329685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S1525001626007185"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.037","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of synthetic TBK1 activator inducing type I interferon-mediated antiviral and antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}